Lung Metastasectomy for Colorectal Carcinoma in Patients with a History of Hepatic Metastasis

被引:10
作者
Chen, Fengshi [1 ]
Shoji, Tsuyoshi [1 ]
Sakai, Hiroaki [1 ]
Miyahara, Ryo [1 ]
Bando, Toru [1 ]
Okubo, Kenichi [1 ]
Date, Hiroshi [1 ]
机构
[1] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
关键词
colorectal carcinoma; liver; lung; metastasectomy; PULMONARY METASTASES; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; PLUS OXALIPLATIN; FINAL REPORT; PHASE-III; CANCER; RESECTION; FLUOROURACIL; RECURRENCE;
D O I
10.5761/atcs.oa.09.01520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We reviewed resection of pulmonary metastases preformed by the Department of Thoracic Surgery at Kyoto University Hospital to confirm the clinical significance of this surgery in patients with colorectal carcinoma and a history of hepatic metastasis. Methods: From 1992 to 2006, 19 patients with colorectal carcinoma and a history of hepatic metastasis underwent a pulmonary metastasectomy. Surgical outcomes of these patients were investigated in terms of various perioperative variables. Results: Sixteen of 19 patients showed metachronous presentation of hepatic and pulmonary metastases, while 3 patients showed synchronous presentation. Overall survival rate after the pulmonary resection was 93%, at 1 year; 75%, at 3 years and 60% at 5 years. Three years after the pulmonary resection, none of the patients with synchronous hepatic and pulmonary metastases survived, while patients with metachronous metastases had an overall survival rate of more than 80%. Interestingly enough, the overall survival curve of the patients with colorectal carcinoma and a history of hepatic metastasis, who underwent a pulmonary metastasectomy was almost the same as that of patients who did not have the surgery, during the same period. Conclusion: Aggressive resection of pulmonary metastases in a select group of colorectal cancer patients with a history of liver metastases might result in prolonged survival.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 21 条
[11]   Pulmonary resection for metastatic colorectal cancer: Experiences with 159 patients [J].
Okumura, S ;
Kondo, M ;
Tsuboi, M ;
Nakayama, H ;
Asamura, H ;
Tsuchiya, R ;
Naruke, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (04) :867-874
[12]  
Pastorino Ugo, 2002, Semin Thorac Cardiovasc Surg, V14, P18, DOI 10.1053/stcs.2002.32881
[13]   LUNG RECURRENCE AFTER CURATIVE SURGERY FOR COLORECTAL-CANCER [J].
PIHL, E ;
HUGHES, ESR ;
MCDERMOTT, FT ;
JOHNSON, WR ;
KATRIVESSIS, H .
DISEASES OF THE COLON & RECTUM, 1987, 30 (06) :417-419
[14]   Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: A final report of the AIO colorectal study group [J].
Porschen, Rainer ;
Arkenau, Hendrik-Tobias ;
Kubicka, Stephan ;
Greil, Richard ;
Seufferlein, Thomas ;
Freier, Werner ;
Kretzschmar, Albrecht ;
Graeven, Ullrich ;
Grothey, Axel ;
Hinke, Axel ;
Schmiegel, Wolff ;
Schmoll, Hans-Joachim .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) :4217-4223
[15]   Surgical treatment of hepatic and pulmonary metastases from colorectal cancers [J].
Regnard, JF ;
Grunenwald, D ;
Spaggiari, L ;
Girard, P ;
Elias, D ;
Ducreux, M ;
Baldeyrou, P ;
Levasseur, P .
ANNALS OF THORACIC SURGERY, 1998, 66 (01) :214-218
[16]   Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience [J].
Rena, O ;
Casadio, C ;
Viano, F ;
Cristofori, R ;
Ruffini, E ;
Filosso, PL ;
Maggi, G .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (05) :906-912
[17]   Histopathologic prognostic factors in resected colorectal lung metastases [J].
Shiono, S ;
Ishii, G ;
Nagai, K ;
Yoshida, J ;
Nishimura, M ;
Murata, Y ;
Tsuta, K ;
Nishiwaki, Y ;
Kodama, T ;
Ochiai, A .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :278-283
[18]  
Simmonds P C, 2000, BMJ, V321, P531
[19]  
Smith J W, 1992, Surg Oncol, V1, P399, DOI 10.1016/0960-7404(92)90042-J
[20]   Surgical therapy of lung metastases [J].
Sternberg, David I. ;
Sonett, Joshua R. .
SEMINARS IN ONCOLOGY, 2007, 34 (03) :186-196